-
NewAmsterdam Pharma (NASDAQ:NAMS) Earns "Buy" Rating from HC Wainwright
ソース: Buzz FX / 14 1 2025 07:16:16 America/Chicago
NewAmsterdam Pharma (NASDAQ:NAMS) Earns "Buy" Rating from HC Wainwright Written by MarketBeat January 14, 2025 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) 's stock had its "buy" rating reaffirmed by
Read more...